Navigation Links
Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
Date:6/9/2009

.

About the TOPS(TM) System

Impliant's TOPS(TM) System, a mobile posterior device, is designed to stabilize but not fuse the L3-4 or L4-5 vertebral level to alleviate pain stemming from spinal stenosis with or without degenerative facet arthrosis, and spondylolisthesis. Following a laminectomy and medial facetectomy, the device is affixed to the spine via four pedicle screws using a standard posterior surgical approach. Impliant believes that the TOPS(TM) System could benefit over 500,000 patients worldwide undergoing spinal fusion surgery each year. The TOPS(TM) System is not approved for sale in the United States.

About Impliant, Inc.

Impliant, Inc. is a privately held company engaged in the development of novel spine arthroplasty solutions for some of the most prevalent pathologies of the spine. The company is currently developing the TOPS(TM) System, which has the longest clinical history in the Total Posterior Arthroplasty market segment, dating to January 2005. Impliant is also developing several next-generation and multi-level technologies to further increase its addressable market. Impliant is headquartered in Princeton, NJ with research facilities located in Ramat Poleg, Israel. Shareholders include Elron Electronic Industries Ltd. (Nasdaq & TASE: ELRN). For more information about Impliant, please visit www.impliant.com.


'/>"/>
SOURCE Impliant, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System
2. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
3. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
4. USC granted $8.4 million for autism research
5. Aida Granted Additional Anti-Cancer Patent
6. CME LLC Granted Five-Year Full Approval by the American Psychological Association
7. ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan
8. TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
9. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
10. Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS
11. Phylonix granted broad European patent for transplanting human cells into zebrafish

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...PYneuron,s most popular and addictive game, SplitW...h. , Mountain View, CA (P...lar and addictive game, SplitWords, is now availab...signed to help banish that ,tip of the tongue, syn...ame challenges the brain by encouraging users to ...
(Date:11/20/2009)...v. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuti...of Shareholders will be held on Monday, December 2... approval of two special resolutions. The first sp...ale of all or substantially all of the assets of N... the asset purchase agreement dated November 10, 2...
(Date:11/20/2009)...Nov. 20 Rates of infecti...d in late October, but the pandemic flu virus cont...ge groups, including the elderly, according to a n... DGX ), the world,s leading provider of diagnost...s most recent Quest Diagnostics Health Trends(TM) ...
(Date:11/20/2009)... The following is a stat...Nevada Health Care Association: ,, "The Nevada ... Senate Majority Leader Harry Reid for his leaders...goal of protecting every Nevada seniors, ongoing a... the strength and viability of our state,s vital f...
(Date:11/20/2009)...ber 20, 2009Emergency medical service (EMS) provid...00 cardiac arrests each year. Only 5 to 10 percen.... Better quality cardiopulmonary resuscitation (C...ssociated with better patient outcome. The Resusc...linical research network to study prehospital trea...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
... Achilles, heel, report suggests , , THURS...Gleevec has forced metastatic melanoma into remiss...Dana-Farber Cancer Institute in Boston. , The case...e patient was enrolled in a clinical trail of the ...
... Sustainable Model for ...ngs, Inc.,(NYSE: ZMH ; SWX: ZMH) today announced ...model aimed at establishing an enhanced standard f...rve,the healthcare markets of the future., The re...
...earch, advocacy and ...hilia Foundation,(NHF) today announced its first-e... the Hemophilia Walk, presented nationally by Baxt...nding to,help find better treatments and cures for...
...ations, Inc. (Amex: IMA ), a global leader in rap...ced that it will release its first quarter,2008 ea...ll also host a,conference call beginning at 10:00 ...uestions concerning business and,financial develop...
...(Nasdaq: YDNT ) today announced that it will broa...ve and on-demand web cast conference call,on Thurs...live audio,broadcast of the call will be available... http://www.ydnt.com ., For those unable to liste...
...es in thinking skills, study finds , , THU...ions known as anticholinergic drugs -- used to tre...son,s disease and urinary incontinence -- may caus...on these drugs does worsen your cognitive performa...
Other Medicine News:Health News:Gleevec Pushes Advanced Melanoma Into Remission 2Health News:Zimmer Announces New Compliance Model 2Health News:Zimmer Announces New Compliance Model 3Health News:Zimmer Announces New Compliance Model 4Health News:Zimmer Announces New Compliance Model 5Health News:Zimmer Announces New Compliance Model 6Health News:Zimmer Announces New Compliance Model 7Health News:National Hemophilia Foundation Asks America to Make a Difference With National Fundraising Initiative 2Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results 2Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2Health News:Common Medications May Harm Memory in Older People 2Health News:Common Medications May Harm Memory in Older People 3
(Date:11/19/2009)...BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -...today announced the pricing of a public offering o...r share, resulting in gross proceeds of $48.75 mil...ryst pursuant to an effective shelf registration s...Exchange Commission. BioCryst has also granted th...
(Date:11/19/2009)...UNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall... announced today that its corporate presentation w...affray Health Care Conference on Wednesday, Decemb...ation will be webcast from The New York Palace Hot...King, Alexza President and CEO. ,, To access ...
(Date:11/19/2009)... NEW YORK, Nov. 19 As the seasons ... is here. Here,s more on preparing yourself. ,,...harmaceuticals Inc. at: ,, http://inr.medias...XAOIF ,, Medialink is a division of The News...audio, text, graphics and photos at http://www.t...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Finalists Perform at Rock Hall in Rainbow Babies 26 Childrens Hospitals Pause to Click Contest Encouraging Safety Belt Use for Tweens 47977 1Finalists Perform at Rock Hall in Rainbow Babies 26 Childrens Hospitals Pause to Click Contest Encouraging Safety Belt Use for Tweens 47977 2President of PRN Funding Appointed to Factoring Association Advisory Board 47974 1President of PRN Funding Appointed to Factoring Association Advisory Board 47974 2Improving livestock productivity in Honduras 8728 1Improving livestock productivity in Honduras 8728 2Improving livestock productivity in Honduras 8728 3
...ence Call to be Held at 9:00 a.m. Eastern Time Tod...United Therapeutics Corporation (Nasdaq: UTHR ) ...ug Administration (FDA) has approved ADCIRCA(TM) (... recommended dose of 40 mg, as the first once-dail...e treatment of pulmonary arterial hypertension (PA...
...LIS, Md., May 22 PharmAthene, Inc. (NYSE Amex: ...ountermeasures against biological and chemical thr...ed its comprehensive regulatory strategy to the U....e non-clinical and clinical development plans for ...inant protective antigen anthrax vaccine. , , The...
Other Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 2PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 3PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 4
...unctional microplate detection system, ,offers the...romising flexibility. ,The Ultra Evolution is Te...atform. New features are available as options whic...nt along with possible upgrade paths should your n...
...roplate based multi-detection reader which incorpo...uorescence Polarization , Fluorescence Intensity ...uminescence (flash and glow) , Absorbance ,It ...adioactive labeled applications:, , Ca2+ Measureme...
...e reader that offers four different measurement mo...e-resolved fluorescence, high-perfomance luminesce...ipped with injectors that deliver reagent at the p...ys can be performed easily and allowing the unit t...
ViewLux ultraHTS Microplate Imager
Medicine Products: